These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16344314)

  • 21. Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer.
    Kim IJ; Lim SB; Kang HC; Chang HJ; Ahn SA; Park HW; Jang SG; Park JH; Kim DY; Jung KH; Choi HS; Jeong SY; Sohn DK; Kim DW; Park JG
    Dis Colon Rectum; 2007 Sep; 50(9):1342-53. PubMed ID: 17665260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
    Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
    Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
    Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus.
    Javeri H; Arora R; Correa AM; Hofstetter WL; Lee JH; Liao Z; McAleer MF; Maru D; Bhutani MS; Swisher SG; Izzo JG; Ajani JA
    Cancer; 2008 Sep; 113(6):1302-8. PubMed ID: 18623381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prediction of response to neoadjuvant chemotherapy in Barrett's carcinoma by quantitative gene expression analysis].
    Langer R; Specht K; Becker K; Ewald P; Sarbia M; Busch R; Feith M; Stein HJ; Siewert JR; Höfler H
    Verh Dtsch Ges Pathol; 2004; 88():207-13. PubMed ID: 16892554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma: loss of chromosome 1q21.3 is associated with shorter overall survival.
    Maru DM; Luthra R; Correa AM; White-Cross J; Anandasabapathy S; Krishnan S; Guha S; Komaki R; Swisher SG; Ajani JA; Hofstetter WL; Rashid A
    Cancer; 2009 Apr; 115(7):1576-85. PubMed ID: 19156915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential gene expression profiling of esophageal adenocarcinoma.
    Hammoud ZT; Badve S; Zhao Q; Li L; Saxena R; Thorat MA; Morimiya A; Rieger KM; Kesler KA
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):829-34. PubMed ID: 19327504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.
    Gottschlich S; Ambrosch P; Cordes C; Görögh T; Schreiber S; Häsler R
    Int J Oncol; 2006 Sep; 29(3):605-13. PubMed ID: 16865276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience.
    Blum Murphy M; Xiao L; Patel VR; Maru DM; Correa AM; G Amlashi F; Liao Z; Komaki R; Lin SH; Skinner HD; Vaporciyan A; Walsh GL; Swisher SG; Sepesi B; Lee JH; Bhutani MS; Weston B; Hofstetter WL; Ajani JA
    Cancer; 2017 Nov; 123(21):4106-4113. PubMed ID: 28885712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
    Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
    Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression of colorectal cancer: preoperative genetic diagnosis using endoscopic biopsies.
    Komori T; Takemasa I; Yamasaki M; Motoori M; Kato T; Kikkawa N; Kawaguchi N; Ikeda M; Yamamoto H; Sekimoto M; Matsubara K; Matsuura N; Monden M
    Int J Oncol; 2008 Feb; 32(2):367-75. PubMed ID: 18202759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide gene expression profile analysis of esophageal squamous cell carcinomas.
    Yamabuki T; Daigo Y; Kato T; Hayama S; Tsunoda T; Miyamoto M; Ito T; Fujita M; Hosokawa M; Kondo S; Nakamura Y
    Int J Oncol; 2006 Jun; 28(6):1375-84. PubMed ID: 16685439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in gene expression induced by chemoradiation in advanced cervical carcinoma: a microarray study of RTOG C-0128.
    Zempolich K; Fuhrman C; Milash B; Flinner R; Greven K; Ryu J; Forbes A; Kerlin K; Nichols RC; Gaffney DK
    Gynecol Oncol; 2008 May; 109(2):275-9. PubMed ID: 18299147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients with ERCC1-negative locally advanced esophageal cancers may benefit from preoperative chemoradiotherapy.
    Kim MK; Cho KJ; Kwon GY; Park SI; Kim YH; Kim JH; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Kim SB
    Clin Cancer Res; 2008 Jul; 14(13):4225-31. PubMed ID: 18594004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
    Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
    J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Establishment of cDNA microarray technology and analysis of gene expression profiles in human esophageal cancer cell line ECa109].
    Li P; Ling Z; Zhao J; Yang H; Huang Y; Zhao M; Dong Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Apr; 25(2):413-8. PubMed ID: 18610633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung.
    Raponi M; Zhang Y; Yu J; Chen G; Lee G; Taylor JM; Macdonald J; Thomas D; Moskaluk C; Wang Y; Beer DG
    Cancer Res; 2006 Aug; 66(15):7466-72. PubMed ID: 16885343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression profiling of esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy: clinical implications.
    Ashida A; Boku N; Aoyagi K; Sato H; Tsubosa Y; Minashi K; Muto M; Ohtsu A; Ochiai A; Yoshida T; Yoshida S; Sasaki H
    Int J Oncol; 2006 Jun; 28(6):1345-52. PubMed ID: 16685435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis.
    Weigelt B; Kreike B; Reis-Filho JS
    Breast Cancer Res Treat; 2009 Sep; 117(2):273-80. PubMed ID: 18815879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts.
    Hayes DN; Monti S; Parmigiani G; Gilks CB; Naoki K; Bhattacharjee A; Socinski MA; Perou C; Meyerson M
    J Clin Oncol; 2006 Nov; 24(31):5079-90. PubMed ID: 17075127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.